CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension [Phase 1]
Summary
Phase 1 study update on ranolazine for pulmonary arterial hypertension reports completed results for acute and short-term administration.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED